We are live on ! Find out more
Syncona Portfolio

Syncona Portfolio Portfolio holdings

AUM $32.3M Turnover 0%
1-Year Est. Return 51.22%
This Fund
S&P 500
This Quarter Est. Return
-44.14%
1 Year Est. Return
+51.22%
3 Year Est. Return
+24.03%
5 Year Est. Return
-64.76%
10 Year Est. Return
–
AUM
$85.9M
AUM Growth
-$64.2M
Cap. Flow
+$3.16M
Cap. Flow %
3.68%
Top 10 Hldgs %
100%
Holding
3
New
1
Increased
–
Reduced
–
Closed
–
Avg Time Held
1.7 years
Top 10 Avg Time Held
1.7 years
Top 20 Avg Time Held
1.7 years

Top Buys

Rank Stock Value
1
IPSC icon
Century Therapeutics
IPSC
+$3.16M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
AUTL icon
1
Autolus Therapeutics
AUTL
$242M
$74.3M 86.51%
21,346,829
– –
2021 Q4
10 quarters
ACHL
2
DELISTED
Achilles Therapeutics
ACHL
$9.04M 10.52%
11,086,909
– –
2021 Q4
10 quarters
IPSC icon
3
Century Therapeutics
IPSC
$212M
$2.55M 2.97%
+1,000,771
New +$3.16M
2024 Q2
0 quarters

Similar funds

Syncona Portfolio's Q2 2024 Portfolio in Review

As of Q2 2024, Syncona Portfolio held 3 positions worth $85.9M, down 43% from $150M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Syncona Portfolio deployed $3.16M of net new capital in Q2 2024, opening 1 new position. Its largest new stake was Century Therapeutics: 1,000,771 shares worth $2.55M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Syncona Portfolio's largest Q2 2024 buy was Century Therapeutics: 1,000,771 shares worth $2.55M.
  • Syncona Portfolio's ten largest holdings make up 100% of its $85.9M portfolio in Q2 2024.
  • Syncona Portfolio opened 1 new position and closed 0 in Q2 2024.
  • Syncona Portfolio's portfolio value fell 43% quarter-over-quarter to $85.9M.

Based on Syncona Portfolio's 13F filing for Q2 2024, filed 13 Aug 2024.